Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II TrialLocke J. Bryan,Carla Casulo,Pamela Allen,Scott E. Smith,Hatice Savas,Reem Karmali,Barbara Pro,Kaitlyn O'Shea,Joan Chmiel,Brett Alan Palmer,Jayesh Mehta,Leo I. Gordon,Jane N. WinterBlood（2021）引用 13|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
